These approaches can result in over‐ or under‐dosing, as they cannot adapt to a patient's changing physiological state.[21] For example, a patient with diabetes using a traditional insulin pump may receive insulin at a predetermined rate, regardless of fluctuating blood sugar levels throughout the day, potentially leading to imbalances.[22] To achieve better treatment for various diseases, the development of advanced, well‐controlled biomedical tools has become increasingly important. This evidence concerns the gene INS and diabetes mellitus.